2009Journal of Pediatric PharmacyRequires access

Clinical Observation of Yinzhihuang Injection in Treating 42 Cases of Neonatal Pathological Jaundice

Youliang Wang

Open publisher page 1 citations

Abstract

Objective:To evaluate the effects of Yinzhihuang injection in treatment of neonatal pathological jaundice.Methods: Forty two cases of pathological neonatal jaundice were administrated with Yinzhihuang injection in the treatment group,compared with conventional treatment in the control group(38 cases).Skin jaundice and bilirubin situation were observed and compared.Results: The efficiency rate and the total effective rate of both groups were significantly different(85.7% and 100% in the treatment group while 57.9% and 81.6% in the control group,χ2=7.74,8.47,P0.05).The bilirubin decrease and the time of decrease were(146±43.98) μmol/L and(5.3±1.64) d in the treatment group while(96±46.13) μmol/L and(7.1±2.15) d in the control group,with obvious differences(t=12.14,2.95,P0.05) in both index.No adverse reactions were observed except for mild diarrheas of 6 cases in the treatment group.Conclusions: Yinzhihuang injection in treatment of neonatal pathological jaundice is safe and effective,worth promoting.

About this research paper

What this paper is about

Objective:To evaluate the effects of Yinzhihuang injection in treatment of neonatal pathological jaundice.Methods: Forty two cases of pathological neonatal jaundice were administrated with Yinzhihuang injection in the treatment group,compared with conventional treatment in the control group(38 cases).Skin jaundice and bilirubin situation were observed and compared.Results: The efficiency rate and the total effective rate of both groups were significantly different(85.7% and 100% in the treatment group while 57.9% and 81.6% in the control group,χ2=7.74,8.47,P0.05).The bilirubin decrease and the time of decrease were(146±43.98) μmol/L and(5.3±1.64) d in the treatment group while(96±46.13) μmol/L and(7.1±2.15) d in the control group,with obvious differences(t=12.14,2.95,P0.05) in both index.No adverse reactions were observed except for mild diarrheas of 6 cases in the treatment group.Conclusions: Yinzhihuang injection in treatment of neonatal pathological jaundice is safe and effective,worth promoting.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the effects of Yinzhihuang injection in treatment of neonatal pathological jaundice.Methods: Forty two cases of pathological neonatal jaundice were administrated with Yinzhihuang injection in the treatment group,compared with conventional treatment in the control group(38 cases).Skin jaundice and bilirubin situation were observed and compared.Results: The efficiency rate and the total effective rate of both groups were significantly different(85.7% and 100% in the treatment group while 57.9% and 81.6% in the control group,χ2=7.74,8.47,P0.05).The bilirubin decrease and the time of decrease were(146±43.98) μmol/L and(5.3±1.64) d in the treatment group while(96±46.13) μmol/L and(7.1±2.15) d in the control group,with obvious differences(t=12.14,2.95,P0.05) in both index.No adverse reactions were observed except for mild diarrheas of 6 cases in the treatment group.Conclusions: Yinzhihuang injection in treatment of neonatal pathological jaundice is safe and effective,worth promoting.

Key concepts: Jaundice, Pathological, Medicine, Bilirubin, Gastroenterology, Internal medicine, Surgery, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation of Yinzhihuang Injection in Treating 42 Cases of Neonatal Pathological Jaundice — Research Paper | ScholarLens